Julia

See full story
Julia was diagnosed with MS when she was 23. Due to mobility issues, she uses a Hemi Walker to move around and has been disabled for fifteen years. Through inquiring about clinical trials, Julia’s doctor connected her to ongoing clinical trials. Julia has participated in a long-term study where she had an MRI, Optical Coherence Tomography (OCT) scan, and blood tests done. She also participated in some movement studies that measured and timed her ability to walk a certain distance. Her latest clinical trial gave her a medication that would alter her intestines and supposedly affect her brain as well. After taking the pills, Julia had to submit stool samples, fill out questionnaires, undergo standard tests involving movement, and closely observe her diet. Julia asked the researcher if in the end, she took the placebo or the real drug, but they never responded. Julia looked up the results of the studies she was a part of because none of the studies communicated their findings to her. Julia remembers signing a lot of papers during the consent process, but she trusts her physician “completely” and does not dwell too much on those details.
Julia’s original motivation for participating in clinical trials “was to see if anything might help.” Eventually, her motivation evolved into the feeling that “even if it doesn't help, it's just a reason for being, right?” By participating in research, Julia feels like she found her mission in this world: to be “useful for someone who is researching this disease.”